Wegovy for sale 0.25mg/0.5ml 4 Pens Manufacturer
Accepted Payment Methods
Cryptocurrency

USDT, BTC (3% Discount)

Also accepts: CNY, USD, HKD, and 8 other currencies

Bank Transfer

Multiple international banking options available

Contact us for specific bank details

SKU N/A Categories ,

Wegovy for sale 0.25mg/0.5ml 4 Pens Manufacturer

$420.00

Wholesale Information

Quick Summary

MOQ: 100 boxes (Approx. 400 prefilled pens based on titration kit) | Price Range: Please Inquire | Lead Time: 7-45 days

Ordering Requirements
Minimum Order Quantity (MOQ)100 boxes (Approx. 400 prefilled pens, based on 4 pens/box)
Repeat ClientsMay negotiate down to 50 boxes
Pricing & Volume Discounts
Order QuantityPrice per Box (Estimated)Total Value (Estimated)
100-499 boxesPlease InquirePlease Inquire
500-999 boxesPlease InquirePlease Inquire
1,000+ boxesPlease InquirePlease Inquire

Note: Prices exclude shipping and tariffs. Valid for 30 days from quote date. Due to varying titration kits, pricing for Wegovy® is available upon direct inquiry.

Product Specifications

Formulation Details

  • Active Ingredient: Semaglutide, a GLP-1 receptor agonist
  • Excipients: Disodium phosphate dihydrate, propylene glycol, phenol, water for injection, hydrochloric acid/sodium hydroxide (for pH adjustment)
  • Appearance: Clear, colorless solution in prefilled pens

Packaging Configuration

Primary PackagingPrefilled, single-use pens (typically 4 pens per box for monthly supply)
Secondary PackagingBoxes containing multiple pens (e.g., 4 pens/box)
Case DimensionsPlease inquire for specific case dimensions based on product configuration.
Gross WeightPlease inquire for gross weight per case.

Storage & Stability

  • Storage: Refrigerate at 2–8°C. Do not freeze.
  • Shelf Life: 24 months unopened (refer to individual product packaging for exact expiry).
  • Stability: After first use, pens can be stored for 6 weeks at room temperature (below 30°C) or in the refrigerator (2-8°C).

Note: The above parameters are for general reference only. Please communicate directly with us for precise and up-to-date product specifications, as packaging and formulations may vary by region and production batch.

Logistics & Shipping

Production Lead Times

Standard Orders (In Stock)Ships within 7 business days
Custom Production30-45 days (requires 30% deposit)

Shipping Options

Express Air Freight3-7 days (recommended for urgent orders)
Ocean Freight20-40 days (cost-effective for bulk orders)
Manufacturing OriginGMP facilities in China

Cold Chain Management

Standard ShippingRefrigerated shipping (2–8°C) is required for Wegovy® to maintain stability.
Hot Climate OptionAdditional insulated packaging and temperature monitoring will be included as standard for optimal product integrity.
Temperature MonitoringData loggers are included as standard for all shipments requiring cold chain.
Payment Terms

Accepted Payment Methods

Bank TransferIndustrial and Commercial Bank of China (ICBC)
CryptocurrencyUSDT, BTC (3% discount)
Other Currencies11 currencies including RMB, USD, HKD

Payment Conditions

  • First-time orders: 100% advance payment
  • Repeat clients: 50% deposit, 50% before shipment
  • Orders >$50,000: Eligible for installment plans (3 payments)
  • Custom production requires 30% non-refundable deposit

Note: Always provide payment confirmation via email after transaction.

Contact Us
"Focuses on large-scale purchases"
"Large-Volume Global Supply"
"Professional Wholesale Partnership"
Description

Wegovy® (semaglutide) Injection

For Chronic Weight Management

Clinical Overview

Wegovy® is an FDA-approved GLP-1 receptor agonist for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with comorbidities. Clinical trials demonstrate a **15% mean body weight reduction** (35 lb from 232 lb baseline) over 68 weeks, with 86% achieving ≥5% weight loss. It regulates appetite through hypothalamic signaling and delays gastric emptying for sustained caloric deficit when used with lifestyle interventions.

Key Benefits

  • Clinically Proven Efficacy: 3X greater weight loss vs placebo in 68-week Phase III studies.
  • Dose-Titration Protocol: 5-step escalation over 20 weeks minimizes GI intolerance for patient comfort.
  • Multi-System Benefits: Improves key cardiometabolic markers such as blood pressure, LDL-C, and HbA1c.
  • Long-Term Maintenance: 2-year extension studies show sustained 15% weight control, promoting lasting results.

Mechanism of Action & Packaging

Mechanism of Action

  • • GLP-1 Analog Technology: Binds to pancreatic and CNS GLP-1 receptors.
  • • Enhances satiety signals and reduces hunger perception.
  • • 94% bioavailability via subcutaneous injection.

Packaging & Dosage

  • • 5-Step Titration Kit (Monthly Supply): Consists of prefilled pens for escalating dosages.
  • • Storage: Refrigerate at 2–8°C. Do not freeze.
  • • Administration: Single-use prefilled pen. Discard after use.

Professional Administration Guidelines

Frequency
Once weekly, any time of day
Injection Sites
Abdomen, thigh, or upper arm
Dose Adjustment
Mandatory 4-week titration period
Storage
2–8°C; Do not freeze
Administration
Single-use prefilled pen; Discard after use

Important Safety Information

Contraindications: Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).

Adverse Effects: Monitor for pancreatitis and gallbladder events. Common side effects may include nausea, diarrhea, vomiting, and constipation.

Professional Note: Individual results may vary. This product is available only through licensed healthcare providers.

Professional Protocols

• Wegovy® Injection requires prescription and professional administration.

• Always follow aseptic techniques during administration.

• Monitor patients for adverse reactions and adherence to the dose-titration schedule.

• Ensure proper patient education on injection technique and storage.

• Novo Nordisk assumes no liability for unsupervised use or improper storage.

Disclaimer

We are an authorized wholesale distributor of pharmaceutical products. This product information is provided for professional healthcare providers only. We do not sell directly to end-users. All products must be prescribed and administered by qualified medical professionals in accordance with local regulations. Product images and stated parameters are for reference only; actual specifications and packaging may require direct communication for confirmation.

Wegovy® (semaglutide) Injection

For Chronic Weight Management

Clinical Overview

Wegovy® is an FDA-approved GLP-1 receptor agonist for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with comorbidities. Clinical trials demonstrate a **15% mean body weight reduction** (35 lb from 232 lb baseline) over 68 weeks, with 86% achieving ≥5% weight loss. It regulates appetite through hypothalamic signaling and delays gastric emptying for sustained caloric deficit when used with lifestyle interventions.

Key Benefits

  • Clinically Proven Efficacy: 3X greater weight loss vs placebo in 68-week Phase III studies.
  • Dose-Titration Protocol: 5-step escalation over 20 weeks minimizes GI intolerance for patient comfort.
  • Multi-System Benefits: Improves key cardiometabolic markers such as blood pressure, LDL-C, and HbA1c.
  • Long-Term Maintenance: 2-year extension studies show sustained 15% weight control, promoting lasting results.

Mechanism of Action & Packaging

Mechanism of Action

  • • GLP-1 Analog Technology: Binds to pancreatic and CNS GLP-1 receptors.
  • • Enhances satiety signals and reduces hunger perception.
  • • 94% bioavailability via subcutaneous injection.

Packaging & Dosage

  • • 5-Step Titration Kit (Monthly Supply): Consists of prefilled pens for escalating dosages.
  • • Storage: Refrigerate at 2–8°C. Do not freeze.
  • • Administration: Single-use prefilled pen. Discard after use.

Professional Administration Guidelines

Frequency
Once weekly, any time of day
Injection Sites
Abdomen, thigh, or upper arm
Dose Adjustment
Mandatory 4-week titration period
Storage
2–8°C; Do not freeze
Administration
Single-use prefilled pen; Discard after use

Important Safety Information

Contraindications: Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).

Adverse Effects: Monitor for pancreatitis and gallbladder events. Common side effects may include nausea, diarrhea, vomiting, and constipation.

Professional Note: Individual results may vary. This product is available only through licensed healthcare providers.

Professional Protocols

• Wegovy® Injection requires prescription and professional administration.

• Always follow aseptic techniques during administration.

• Monitor patients for adverse reactions and adherence to the dose-titration schedule.

• Ensure proper patient education on injection technique and storage.

• Novo Nordisk assumes no liability for unsupervised use or improper storage.

Disclaimer

We are an authorized wholesale distributor of pharmaceutical products. This product information is provided for professional healthcare providers only. We do not sell directly to end-users. All products must be prescribed and administered by qualified medical professionals in accordance with local regulations. Product images and stated parameters are for reference only; actual specifications and packaging may require direct communication for confirmation.

ProType

0.25mg, 0.5mg, 1.7mg, 1mg, 2.4mg

Reviews

There are no reviews yet.

Be the first to review “Wegovy for sale 0.25mg/0.5ml 4 Pens Manufacturer”

Related products

Quick links

Get connected with us:

Facebook-square Instagram

Contact us:

  • WhatsApp: +85260252494
  • Email: [email protected]
  • Address: Sea Meadow House P.O. Box 116 Road Town Tortola
  • VG1110 VIRGIN ISLANDS, BRITISH
© 2024
    American Express Diners Club Discover Google Pay Maestro Mastercard Shop Pay Union Pay Visa
en_USEnglish
zh_HKChinese en_USEnglish
Scroll to Top
If necessary, please fill in the following information to contact us
Blank Form (#3)